Table 3 CAR-T cell therapy in clinical trials for head and neck cancers
From: A review on the advances and challenges of immunotherapy for head and neck cancer
Target | Phase | Sponsor | ClinicalTrials.gov Identifier |
|---|---|---|---|
ErbB | I/II | King's College London | NCT01818323 |
HER2 | I | Baylor College of Medicine | NCT03740256 |
EpCAM | I | Sichuan University | NCT02915445 |
NKG2D | I | CytoMed Therapeutics Pte Ltd | NCT04107142 |
LMP1 | I/II | The Second Hospital of Nanjing Medical University | NCT02980315 |
LMP1, LMP2, and EBNA1 | II | Fujian Cancer Hospital | NCT03648697 |